Bluejay Diagnostics, Inc.
BJDX · NASDAQ
Bulios Fair Price
$1.22
29.5% upside
Current Price
$0.94
According to Bulios Fair Price, BJDX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Bluejay Diagnostics, Inc. (BJDX) is a company focused on diagnostic technologies and innovative medical tests. Its products and technologies are geared towards early detection and diagnosis of various diseases and health conditions. Bluejay Diagnostics aims to develop accurate, fast, and user-friendly diagnostic tests that can be used in hospitals, clinics, laboratories, and even at home by patients. The company emphasizes innovation and research to provide healthcare professionals and patients with reliable and effective tools for diagnosing and treating various diseases. Bluejay Diagnostics aims to contribute to improving the health status and quality of life of patients. Shares of Bluejay Diagnostics, Inc. (BJDX) can represent an interesting investment opportunity for those who believe in the growth potential of diagnostic technologies and the innovative healthcare industry.
Sector
Healthcare
Industry
Medical - Devices
CEO
Indranil Dey
Employees
6
Headquarters
Acton
Upcoming events
Earnings
Upcoming earnings report